Showing results (481-490 of 723) with videos related to

Sort By:
Pageof 73
European Heart Journal|April 23, 2009
Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipientsEugenia Raichlin, Abhiram Prasad, Walter K Kremers, et al.
Circulation|August 1, 1994
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and plateletsA Mailhac, J J Badimon, J T Fallon, et al.
Circulation|November 1, 2000
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitusP R Moreno, A M Murcia, I F Palacios, et al.
The American Journal of Cardiology|March 1, 1983
In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirinC W Pumphrey, J H Chesebro, M K Dewanjee, et al.
Journal of Thrombosis and Haemostasis : JTH|January 24, 2007
Normalization of platelet reactivity in clopidogrel-treated subjectsG Vilahur, B G Choi, M U Zafar, et al.
Circulation|February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirinJ S Mruk, P Zoldhelyi, M W Webster, et al.
Journal of the American College of Cardiology|December 29, 2000
Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplastyM Roqué, E D Reis, V Fuster, et al.
Cardiovascular Drugs and Therapy|May 21, 2014
Novel anticoagulants for stroke prevention in patients with atrial fibrillationA Jalota, T M Scarabelli, L Saravolatz, et al.
British Heart Journal|October 1, 1991
Relation between cyclic variation in echo amplitude and segmental contraction in normal and abnormal heartsD A Lythall, R B Logan-Sinclair, C J Ilsley, et al.
Circulation|November 1, 1993
Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parametersP Zoldhelyi, M W Webster, V Fuster, et al.
Pageof 73